Compatibility with Osteoporosis Medications When considering the use of GLP-1RAs in patients undergoing treatment for osteoporosis, it is essential to review potential interactions with commonly prescribed osteoporosis medications, such as bisphosphonates and denosumab
Competitive athletes subject to WADA testing should treat these compounds as banned
A helpful way to picture it is a factory: Raising NAD+ is like upgrading the engines so the factory can produce more
Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, et al
They have also been shown to reduce blood pressure and lower the risk of chronic diseases such as heart disease, kidney disease, and liver disease
Maybe not because thats pretty much what happened to elderly laboratory rats when they were fed two dietary supplements in a recent landmark study